
Neovasc NVCN
Quarterly report 2021-Q4
added 05-16-2026
Neovasc Operating Expenses 2011-2026 | NVCN
Annual Operating Expenses Neovasc
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|
| - | 36.4 M | 31.6 M | 32.6 M | 34.8 M | 138 M | 24.7 M | 21.5 M | 11.1 M | 8.15 M | 5.82 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 138 M | 5.82 M | 34.4 M |
Operating Expenses of other stocks in the Medical devices industry
| Issuer | Operating Expenses | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
GenMark Diagnostics, Inc.
GNMK
|
79 M | - | - | $ 1.77 B | ||
|
Avinger
AVGR
|
18.6 M | - | -20.74 % | $ 369 K | ||
|
Axonics Modulation Technologies
AXNX
|
301 M | - | - | $ 3.31 B | ||
|
IRIDEX Corporation
IRIX
|
21.8 M | $ 1.01 | - | $ 17.1 M | ||
|
Allied Healthcare Products
AHPI
|
7.81 M | - | 3.58 % | $ 2.21 M | ||
|
Obalon Therapeutics, Inc.
OBLN
|
11.2 M | - | -5.86 % | $ 30.6 M | ||
|
ClearPoint Neuro
CLPT
|
15.3 M | $ 11.44 | -2.22 % | $ 324 M | ||
|
Apollo Endosurgery
APEN
|
73.8 M | - | - | $ 475 M | ||
|
Alphatec Holdings
ATEC
|
614 M | $ 8.27 | 0.49 % | $ 1.24 B | ||
|
Aziyo Biologics
AZYO
|
33.5 M | - | 1.37 % | $ 20.5 M | ||
|
EDAP TMS S.A.
EDAP
|
47.1 M | $ 4.3 | -2.27 % | $ 161 M | ||
|
BioSig Technologies
BSGM
|
71.1 M | - | 37.08 % | $ 85.7 M | ||
|
BIOLASE
BIOL
|
34.7 M | - | -13.19 % | $ 166 K | ||
|
Conformis
CFMS
|
69.5 M | - | - | $ 16.4 M | ||
|
LivaNova PLC
LIVN
|
697 M | $ 73.83 | 0.26 % | $ 4.03 B | ||
|
Cardiovascular Systems
CSII
|
209 M | - | 0.15 % | $ 844 M | ||
|
LENSAR
LNSR
|
32.6 M | $ 6.09 | 2.35 % | $ 72.8 M | ||
|
Helius Medical Technologies
HSDT
|
249 M | $ 2.29 | -2.97 % | $ 50.5 M | ||
|
CryoLife, Inc.
CRY
|
165 M | - | -4.14 % | $ 702 M | ||
|
Cytosorbents Corporation
CTSO
|
41.2 M | $ 0.46 | 0.17 % | $ 28.6 M | ||
|
OrthoPediatrics Corp.
KIDS
|
212 M | $ 18.37 | -0.33 % | $ 431 M | ||
|
Delcath Systems
DCTH
|
72.8 M | $ 11.02 | -3.76 % | $ 395 M | ||
|
Soliton, Inc.
SOLY
|
14.4 M | - | -1.42 % | $ 435 M | ||
|
Hancock Jaffe Laboratories, Inc.
HJLI
|
9.14 K | - | -1.98 % | $ 98.3 M | ||
|
Itamar Medical Ltd.
ITMR
|
39.1 M | - | 0.03 % | $ 1.58 B | ||
|
Misonix, Inc.
MSON
|
63.1 M | - | - | $ 462 M | ||
|
Dynatronics Corporation
DYNT
|
18.1 M | - | 14.99 % | $ 929 K | ||
|
Eargo
EAR
|
126 M | - | - | $ 10.2 M | ||
|
MiMedx Group
MDXG
|
277 M | $ 3.62 | 0.28 % | $ 535 M | ||
|
Pulmonx Corporation
LUNG
|
121 M | $ 1.55 | 0.65 % | $ 63.1 M | ||
|
Electromed
ELMD
|
40.3 M | $ 38.22 | -0.93 % | $ 323 M | ||
|
Myomo
MYO
|
41.3 M | $ 1.04 | 9.5 % | $ 43.5 M | ||
|
Butterfly Network
BFLY
|
132 M | $ 4.47 | -0.11 % | $ 1.1 B | ||
|
Intersect ENT, Inc.
XENT
|
118 M | - | - | $ 955 M | ||
|
Second Sight Medical Products
EYES
|
27.6 M | - | -0.97 % | $ 54.4 M | ||
|
Sintx Technologies
SINT
|
11.2 M | $ 2.39 | 3.91 % | $ 6.63 M | ||
|
Orthofix Medical
OFIX
|
344 M | $ 10.75 | 3.27 % | $ 426 M | ||
|
GBS
GBS
|
12.7 M | - | -0.57 % | $ 7.12 M | ||
|
Profound Medical Corp.
PROF
|
52.6 M | $ 6.83 | -2.01 % | $ 206 M | ||
|
Globus Medical
GMED
|
887 M | $ 84.81 | 0.24 % | $ 11.5 B | ||
|
Insulet Corporation
PODD
|
531 M | $ 154.87 | -1.29 % | $ 10.9 B | ||
|
CONMED Corporation
CNMD
|
648 M | $ 37.23 | 0.57 % | $ 1.16 B | ||
|
Inspire Medical Systems
INSP
|
240 M | $ 43.84 | -2.01 % | $ 1.29 B | ||
|
Integer Holdings Corporation
ITGR
|
279 M | $ 89.28 | -0.8 % | $ 3.1 B | ||
|
TransMedics Group
TMDX
|
254 M | $ 68.94 | 0.12 % | $ 2.34 B | ||
|
Invacare Corporation
IVC
|
260 M | - | - | $ 24.7 M | ||
|
Edwards Lifesciences Corporation
EW
|
1.99 B | $ 85.78 | 3.1 % | $ 50.2 B |